137 related articles for article (PubMed ID: 17440326)
1. Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals.
Calandrino R; del Vecchio A; Todde S; Fazio F
Health Phys; 2007 May; 92(5 Suppl):S70-7. PubMed ID: 17440326
[TBL] [Abstract][Full Text] [Related]
2. Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons.
Calandrino R; del Vecchio A; Parisi R; Todde S; De Felice P; Savi A; Pepe A; Mrskova A
Radiat Prot Dosimetry; 2010 Jun; 139(4):477-82. PubMed ID: 20028699
[TBL] [Abstract][Full Text] [Related]
3. Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility.
Calandrino R; del Vecchio A; Savi A; Todde S; Belloli S
Health Phys; 2009 Oct; 97(4):315-21. PubMed ID: 19741360
[TBL] [Abstract][Full Text] [Related]
4. Management of radioactive waste gases from PET radiopharmaceutical synthesis using cost effective capture systems integrated with a cyclotron safety system.
Stimson DH; Pringle AJ; Maillet D; King AR; Nevin ST; Venkatachalam TK; Reutens DC; Bhalla R
J Radiol Prot; 2016 Sep; 36(3):504-517. PubMed ID: 27383139
[TBL] [Abstract][Full Text] [Related]
5. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
6. The radioprotection management of a PET department with a cyclotron and radiopharmacy laboratory, in accordance with Italian legislation.
Russo AA; Ferrari P; Casale M; Delia R
Radiat Prot Dosimetry; 2011 Sep; 147(1-2):240-6. PubMed ID: 22039292
[TBL] [Abstract][Full Text] [Related]
7. Review on production of 89Zr in a medical cyclotron for PET radiopharmaceuticals.
Kasbollah A; Eu P; Cowell S; Deb P
J Nucl Med Technol; 2013 Mar; 41(1):35-41. PubMed ID: 23327781
[TBL] [Abstract][Full Text] [Related]
8. Non-standard radionuclide production for PET in Japan.
Fujibayashi Y; Suzuki K; Fukumura T; Mori T; Kasamatsu S
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):140-4. PubMed ID: 18043540
[TBL] [Abstract][Full Text] [Related]
9. [Use of a cyclotron in the production of positron emitting radionuclides].
Martí-Climent J; Peñuelas I; Calvo R; Giménez M; Gámez C; Richter J
Rev Esp Med Nucl; 1999 Aug; 18(4):261-7. PubMed ID: 10481107
[TBL] [Abstract][Full Text] [Related]
10. Assessment of internal contamination hazard and fast monitoring for workers involved in maintenance operations on PET cyclotrons.
Terranova N; Testoni R; Cicoria G; Mostacci D; Marengo M
Radiat Prot Dosimetry; 2011 Mar; 144(1-4):468-72. PubMed ID: 21051437
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of pulmonary nodules and lung cancer with one-inch crystal gamma coincidence positron emission tomography/CT versus dedicated positron emission tomography/CT.
Moodie K; Cherk MH; Lau E; Turlakow A; Skinner S; Hicks RJ; Kelly MJ; Kalff V
J Med Imaging Radiat Oncol; 2009 Feb; 53(1):32-9. PubMed ID: 19453526
[TBL] [Abstract][Full Text] [Related]
12. Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland.
Hohn A; Zimmermann K; Schaub E; Hirzel W; Schubiger PA; Schibli R
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):145-50. PubMed ID: 18174878
[TBL] [Abstract][Full Text] [Related]
13. Effective production of ⁶⁵Zn with a PET cyclotron.
Lucconi G; Cicoria G; Pancaldi D; Malizia C; Marengo M
Appl Radiat Isot; 2012 Aug; 70(8):1590-4. PubMed ID: 22732395
[TBL] [Abstract][Full Text] [Related]
14. Experimental measurement and Monte Carlo assessment of Argon-41 production in a PET cyclotron facility.
Infantino A; Valtieri L; Cicoria G; Pancaldi D; Mostacci D; Marengo M
Phys Med; 2015 Dec; 31(8):991-996. PubMed ID: 26420444
[TBL] [Abstract][Full Text] [Related]
15. Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time.
Calandrino R; del Vecchio A; Savi A; Todde S; Griffoni V; Brambilla S; Parisi R; Simone G; Fazio F
Health Phys; 2006 Jun; 90(6):588-96. PubMed ID: 16691108
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical preparation of oxygen-15 labelled molecular oxygen and carbon monoxide gasses in a hospital setting.
Luurtsema G; Boellaard R; Greuter HN; Rijbroek A; Takkenkamp K; de Geest FG; Buijs FL; Harry Hendrikse N; Franssen EJ; van Lingen A; Lammertsma AA
J Clin Pharm Ther; 2010 Feb; 35(1):63-9. PubMed ID: 20175813
[TBL] [Abstract][Full Text] [Related]
17. Radionuclide production and yields at Washington University School of Medicine.
Tang L
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):121-33. PubMed ID: 18043542
[TBL] [Abstract][Full Text] [Related]
18. A real-time positron monitor for the estimation of stack effluent releases from PET medical cyclotron facilities.
Mukherjee B
Appl Radiat Isot; 2002 Dec; 57(6):899-905. PubMed ID: 12406635
[TBL] [Abstract][Full Text] [Related]
19. Experimental monitoring of ozone production in a PET cyclotron facility.
Zanibellato L; Cicoria G; Pancaldi D; Boschi S; Mostacci D; Marengo M
Appl Radiat Isot; 2010 Oct; 68(10):1933-6. PubMed ID: 20483623
[TBL] [Abstract][Full Text] [Related]
20. Indoor radon concentrations in Adana, Turkey.
Degerlier M; Celebi N
Radiat Prot Dosimetry; 2008; 131(2):259-64. PubMed ID: 18469346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
